BT-13

N/A

Report date: 2025/01/15 13:55:02
NME

Base Information

Drug NameBT-13
Drug Alias NameBT-13 (Genecode/University of Helsinki)MIM-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlial cell line-derived neurotrophic factor receptors agonists
TargetsGlial cell line-derived neurotrophic factor receptors
Therapy Area/IndicationsDiabetic peripheral neuropathyParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinlandEstonia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenecode
China Registration ClassN/A

Develop Information

Active CompaniesGenecodeUniversity Of Helsinki
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A